Instil Bio, Inc. Construction in Progress, Gross
Instil Bio, Inc. (TIL) had Construction in Progress, Gross of $104.00 million as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:ConstructionInProgressGross · last filed 2023-03-31
- 2022-12-31: Construction in Progress, Gross $104.00M.
- 2021-12-31: Construction in Progress, Gross $67.00M.
- 2021-09-30: Construction in Progress, Gross $44.20M.
- 2021-06-30: Construction in Progress, Gross $22.60M.
| Period end | Construction in Progress, Gross |
|---|---|
| 2022-12-31 | $104.00M 10-K · filed 2023-03-31 |
| 2021-12-31 | $67.00M 10-K · filed 2022-03-07 |
| 2021-09-30 | $44.20M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $22.60M 10-Q · filed 2021-08-12 |
| 2020-12-31 | $6.30M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |